Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kah-Whye Peng

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Molecular Therapy Oncolytics|May 13, 2021
A brief review of reporter gene imaging in oncolytic virotherapy and gene therapySusanna C Concilio, Stephen J Russell, Kah-Whye Peng
Journal of Virology|January 4, 2013
Neuroattenuation of vesicular stomatitis virus through picornaviral internal ribosome entry sitesArun Ammayappan, Rebecca Nace, Kah-Whye Peng, et al.
Cancer Research|July 17, 2004
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virusBambi D Anderson, Takafumi Nakamura, Stephen J Russell, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 20, 2019
Oncolytic Viruses: Priming Time for Cancer ImmunotherapyLuke Russell, Kah Whye Peng, Stephen J Russell, et al.
Virology|November 3, 2004
Reengineering paramyxovirus tropismElizabeth M Hadac, Kah-Whye Peng, Takafumi Nakamura, et al.
Gene|April 7, 2015
Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumorsDavid R Deyle, Diana Zarate Escobar, Kah-Whye Peng, et al.
The Prostate|April 16, 2009
Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancerChunsheng Liu, Kosei Hasegawa, Stephen J Russell, et al.
Human Gene Therapy|December 17, 2011
Retargeting vesicular stomatitis virus using measles virus envelope glycoproteinsCamilo Ayala-Breton, Glen N Barber, Stephen J Russell, et al.
Nature Medicine|May 2, 2002
Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptidesKah-Whye Peng, Suzanne Facteau, Troy Wegman, et al.
Human Gene Therapy|October 3, 2014
8th international conference on oncolytic virus therapeuticsBarbara-Ann Guinn, Lynne Braidwood, Alan Parker, et al.
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Molecular Therapy Oncolytics|May 13, 2021
A brief review of reporter gene imaging in oncolytic virotherapy and gene therapySusanna C Concilio, Stephen J Russell, Kah-Whye Peng
Journal of Virology|January 4, 2013
Neuroattenuation of vesicular stomatitis virus through picornaviral internal ribosome entry sitesArun Ammayappan, Rebecca Nace, Kah-Whye Peng, et al.
Cancer Research|July 17, 2004
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virusBambi D Anderson, Takafumi Nakamura, Stephen J Russell, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 20, 2019
Oncolytic Viruses: Priming Time for Cancer ImmunotherapyLuke Russell, Kah Whye Peng, Stephen J Russell, et al.
Virology|November 3, 2004
Reengineering paramyxovirus tropismElizabeth M Hadac, Kah-Whye Peng, Takafumi Nakamura, et al.
Gene|April 7, 2015
Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumorsDavid R Deyle, Diana Zarate Escobar, Kah-Whye Peng, et al.
The Prostate|April 16, 2009
Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancerChunsheng Liu, Kosei Hasegawa, Stephen J Russell, et al.
Human Gene Therapy|December 17, 2011
Retargeting vesicular stomatitis virus using measles virus envelope glycoproteinsCamilo Ayala-Breton, Glen N Barber, Stephen J Russell, et al.
Nature Medicine|May 2, 2002
Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptidesKah-Whye Peng, Suzanne Facteau, Troy Wegman, et al.
Human Gene Therapy|October 3, 2014
8th international conference on oncolytic virus therapeuticsBarbara-Ann Guinn, Lynne Braidwood, Alan Parker, et al.
Pageof 12